point prevalence survey, antimicrobial use in nhs datamost commonly given for urinary tract...
TRANSCRIPT
![Page 1: Point Prevalence Survey, Antimicrobial Use in NHs dataMost commonly given for urinary tract infection, 30% of all AU – UTI AU prevalence varies across NHs • More than 10 -fold](https://reader035.vdocument.in/reader035/viewer/2022081615/5fe53cf908a39c50075cb536/html5/thumbnails/1.jpg)
National Center for Emerging and Zoonotic Infectious Diseases
Point Prevalence Survey of Healthcare Associated Infection (HAI) and Antimicrobial use (AU) in US nursing homes:
Summary of Antimicrobial use (AU) data
Data from Centers for Disease Control and Prevention (CDC)& the Emerging Infections Program (EIP)
July 11, 2019
Nicola Thompson, MSc, PhDDivision of Healthcare Quality Promotion, CDC
![Page 2: Point Prevalence Survey, Antimicrobial Use in NHs dataMost commonly given for urinary tract infection, 30% of all AU – UTI AU prevalence varies across NHs • More than 10 -fold](https://reader035.vdocument.in/reader035/viewer/2022081615/5fe53cf908a39c50075cb536/html5/thumbnails/2.jpg)
Primary objectives: CDC 2017 NH prevalence survey
Stone at al. ICHE 2012
Measure number/proportion of HAIs and HAI types in nursing homes– Using revised McGeer criteria for residents in LTC1
Identify number/proportion and types of antimicrobial drugs used in nursing home residents
![Page 3: Point Prevalence Survey, Antimicrobial Use in NHs dataMost commonly given for urinary tract infection, 30% of all AU – UTI AU prevalence varies across NHs • More than 10 -fold](https://reader035.vdocument.in/reader035/viewer/2022081615/5fe53cf908a39c50075cb536/html5/thumbnails/3.jpg)
CDC Prevalence Survey: Definition of Antimicrobial Use
Systemic antimicrobial(s) received by residents at the time of the survey– Drug name and class– Administration route– Rationale: Treatment of infection, Prophylaxis, Non-infectious– Therapeutic body site– First date and End date: Planned duration
Systemic: Oral/Enteral, Intravenous, Intramuscular or Inhaled route of administration– Main exclusions : Topical, Ophthalmic, Otic, Intranasal
Antimicrobial: List of 130 eligible agents– Mostly antibiotics, but also selected antifungal or antiviral agents
![Page 4: Point Prevalence Survey, Antimicrobial Use in NHs dataMost commonly given for urinary tract infection, 30% of all AU – UTI AU prevalence varies across NHs • More than 10 -fold](https://reader035.vdocument.in/reader035/viewer/2022081615/5fe53cf908a39c50075cb536/html5/thumbnails/4.jpg)
Prevalence of systemic antimicrobial use (AU) in nursing homes, 2017
# NH # NH residents
# residents>1 AU
AU prevalence 100residents
161 15,276 1,261 8.2%
Thompson et al. Abstract Presented at IDWeek 2018. San Francisco, CA
![Page 5: Point Prevalence Survey, Antimicrobial Use in NHs dataMost commonly given for urinary tract infection, 30% of all AU – UTI AU prevalence varies across NHs • More than 10 -fold](https://reader035.vdocument.in/reader035/viewer/2022081615/5fe53cf908a39c50075cb536/html5/thumbnails/5.jpg)
Prevalence of systemic antimicrobial use (AU) in nursing homes, 2017
# NH # NH residents
# residents>1 AU
AU prevalence 100residents
161 15,276 1,261 8.2%
Thompson et al. Abstract Presented at IDWeek 2018. San Francisco, CA
![Page 6: Point Prevalence Survey, Antimicrobial Use in NHs dataMost commonly given for urinary tract infection, 30% of all AU – UTI AU prevalence varies across NHs • More than 10 -fold](https://reader035.vdocument.in/reader035/viewer/2022081615/5fe53cf908a39c50075cb536/html5/thumbnails/6.jpg)
Prevalence of systemic antimicrobial use (AU) in nursing homes compared to U.S acute care hospitals
Magill et al. JAMA, 2015
![Page 7: Point Prevalence Survey, Antimicrobial Use in NHs dataMost commonly given for urinary tract infection, 30% of all AU – UTI AU prevalence varies across NHs • More than 10 -fold](https://reader035.vdocument.in/reader035/viewer/2022081615/5fe53cf908a39c50075cb536/html5/thumbnails/7.jpg)
Prevalence of systemic antimicrobial use (AU) in nursing homes compared to LTCF in European
https:// ecdc.europa.eu/en/healthcare-associated-infections-long-term-care-facilities
![Page 8: Point Prevalence Survey, Antimicrobial Use in NHs dataMost commonly given for urinary tract infection, 30% of all AU – UTI AU prevalence varies across NHs • More than 10 -fold](https://reader035.vdocument.in/reader035/viewer/2022081615/5fe53cf908a39c50075cb536/html5/thumbnails/8.jpg)
Percent of antimicrobial drugs by route of administration
0% 20% 40% 60% 80% 100%
Oral/enteral Intravenous Intramuscular Inhaled
Thompson et al. Abstract Presented at IDWeek 2018. San Francisco, CA
![Page 9: Point Prevalence Survey, Antimicrobial Use in NHs dataMost commonly given for urinary tract infection, 30% of all AU – UTI AU prevalence varies across NHs • More than 10 -fold](https://reader035.vdocument.in/reader035/viewer/2022081615/5fe53cf908a39c50075cb536/html5/thumbnails/9.jpg)
Percent of antimicrobial drugs by rationale for use
0% 20% 40% 60% 80% 100%
Tx. active infection Medical proph Non-infectiousNot documented Surgical prophy
Thompson et al. Abstract Presented at IDWeek 2018. San Francisco, CA
![Page 10: Point Prevalence Survey, Antimicrobial Use in NHs dataMost commonly given for urinary tract infection, 30% of all AU – UTI AU prevalence varies across NHs • More than 10 -fold](https://reader035.vdocument.in/reader035/viewer/2022081615/5fe53cf908a39c50075cb536/html5/thumbnails/10.jpg)
Top 10 antibiotic classes – overall
0% 2% 4% 6% 8% 10% 12% 14% 16%
Fluoroquinolones
1st-gen cephalosp.
Comb. sulfonamides & trimethroprim, derivatives
Tetracyclines
Antibiotics, Intestinal anti-infectives
Comb. penicillins, inc. beta-lactamase inhibitors
3rd-gen cephalosp.
Nitrofuran derivatives
Glycopeptides
Penicillins with Extended Spectrum
Thompson et al. Abstract Presented at IDWeek 2018. San Francisco, CA
![Page 11: Point Prevalence Survey, Antimicrobial Use in NHs dataMost commonly given for urinary tract infection, 30% of all AU – UTI AU prevalence varies across NHs • More than 10 -fold](https://reader035.vdocument.in/reader035/viewer/2022081615/5fe53cf908a39c50075cb536/html5/thumbnails/11.jpg)
Percent of antimicrobial drugs by treatment site(s)
0% 5% 10% 15% 20% 25% 30%
Uninary tract
Skin or wound
Respiratory tract
Bone/joint
Other
Gastrointestinal
Ear, nose, mouth
Bloodstream
Sepsis
Genital tract
Eye
Thompson et al. Abstract Presented at IDWeek 2018. San Francisco, CA
UTI almost 1/3
![Page 12: Point Prevalence Survey, Antimicrobial Use in NHs dataMost commonly given for urinary tract infection, 30% of all AU – UTI AU prevalence varies across NHs • More than 10 -fold](https://reader035.vdocument.in/reader035/viewer/2022081615/5fe53cf908a39c50075cb536/html5/thumbnails/12.jpg)
Urinary tract infection: a leading cause of antimicrobial use in nursing homes
European CDC: Prevalence Survey in Long-term Care Facilities, 2013. Antimicrobials Used
Urinary tract, 48%Infection type %1. Respiratory tract 36
2. Urinary tract 33
3. Skin/soft tissue 13
Loeb. Ontario, Canada Chronic Care Facilities, 1997. Antibiotics Used
![Page 13: Point Prevalence Survey, Antimicrobial Use in NHs dataMost commonly given for urinary tract infection, 30% of all AU – UTI AU prevalence varies across NHs • More than 10 -fold](https://reader035.vdocument.in/reader035/viewer/2022081615/5fe53cf908a39c50075cb536/html5/thumbnails/13.jpg)
>10-fold variation in NH-specific prevalence of antibiotic use for UTI
Thompson et al. Abstract Presented at Society for Healthcare Epidemiologists in America 2019. Boston, MA
![Page 14: Point Prevalence Survey, Antimicrobial Use in NHs dataMost commonly given for urinary tract infection, 30% of all AU – UTI AU prevalence varies across NHs • More than 10 -fold](https://reader035.vdocument.in/reader035/viewer/2022081615/5fe53cf908a39c50075cb536/html5/thumbnails/14.jpg)
>10-fold variation in NH-specific prevalence of antibiotic use for UTI
50% NH25% NH25% NH
Thompson et al. Abstract Presented at Society for Healthcare Epidemiologists in America 2019. Boston, MA
![Page 15: Point Prevalence Survey, Antimicrobial Use in NHs dataMost commonly given for urinary tract infection, 30% of all AU – UTI AU prevalence varies across NHs • More than 10 -fold](https://reader035.vdocument.in/reader035/viewer/2022081615/5fe53cf908a39c50075cb536/html5/thumbnails/15.jpg)
Top 10 antibiotic classes for UTI
Thompson et al. Abstract Presented at Society for Healthcare Epidemiologists in America 2019. Boston, MA
![Page 16: Point Prevalence Survey, Antimicrobial Use in NHs dataMost commonly given for urinary tract infection, 30% of all AU – UTI AU prevalence varies across NHs • More than 10 -fold](https://reader035.vdocument.in/reader035/viewer/2022081615/5fe53cf908a39c50075cb536/html5/thumbnails/16.jpg)
Antibiotic for UTI ≠ UTI Surveillance Event
NHSN LTCF Component provides criteria to identify UTI Events for surveillance purposes
Clinical guidelines are used to guide decisions on when to initiate antibiotics for suspected UTI, one example– Loeb Minimum Criteria for Initiation of Antibiotics
• Undergoing an update
They are different!– Because they not used for the same purpose
![Page 17: Point Prevalence Survey, Antimicrobial Use in NHs dataMost commonly given for urinary tract infection, 30% of all AU – UTI AU prevalence varies across NHs • More than 10 -fold](https://reader035.vdocument.in/reader035/viewer/2022081615/5fe53cf908a39c50075cb536/html5/thumbnails/17.jpg)
![Page 18: Point Prevalence Survey, Antimicrobial Use in NHs dataMost commonly given for urinary tract infection, 30% of all AU – UTI AU prevalence varies across NHs • More than 10 -fold](https://reader035.vdocument.in/reader035/viewer/2022081615/5fe53cf908a39c50075cb536/html5/thumbnails/18.jpg)
Thompson et al. Abstract Presented at IDWeek 2018. San Francisco, CA
Self-reported data on implementation of 15 activities in 7 domains of the CDC Core Elements, 161 NH
![Page 19: Point Prevalence Survey, Antimicrobial Use in NHs dataMost commonly given for urinary tract infection, 30% of all AU – UTI AU prevalence varies across NHs • More than 10 -fold](https://reader035.vdocument.in/reader035/viewer/2022081615/5fe53cf908a39c50075cb536/html5/thumbnails/19.jpg)
Thompson et al. Abstract Presented at IDWeek 2018. San Francisco, CA
![Page 20: Point Prevalence Survey, Antimicrobial Use in NHs dataMost commonly given for urinary tract infection, 30% of all AU – UTI AU prevalence varies across NHs • More than 10 -fold](https://reader035.vdocument.in/reader035/viewer/2022081615/5fe53cf908a39c50075cb536/html5/thumbnails/20.jpg)
Range in facility stewardship score
Thompson et al. Abstract Presented at IDWeek 2018. San Francisco, CA
![Page 21: Point Prevalence Survey, Antimicrobial Use in NHs dataMost commonly given for urinary tract infection, 30% of all AU – UTI AU prevalence varies across NHs • More than 10 -fold](https://reader035.vdocument.in/reader035/viewer/2022081615/5fe53cf908a39c50075cb536/html5/thumbnails/21.jpg)
![Page 22: Point Prevalence Survey, Antimicrobial Use in NHs dataMost commonly given for urinary tract infection, 30% of all AU – UTI AU prevalence varies across NHs • More than 10 -fold](https://reader035.vdocument.in/reader035/viewer/2022081615/5fe53cf908a39c50075cb536/html5/thumbnails/22.jpg)
Summary AU prevalence in US nursing homes was 8.2 per 100 NH residents
– On a given day, 1 in 12 residents receiving an antimicrobial– Much lower than in US acute hospitals– But, double prevalence in European LTC facilities
Most commonly given for urinary tract infection, 30% of all AU– UTI AU prevalence varies across NHs
• More than 10-fold difference in NH prevalence rates– Remember, antibiotic given for UTI is not the same as UTI Event for
surveillance
CDC Core Elements for Antibiotic Stewardship are being adopted by nursing homes, opportunities for improvement remain
![Page 23: Point Prevalence Survey, Antimicrobial Use in NHs dataMost commonly given for urinary tract infection, 30% of all AU – UTI AU prevalence varies across NHs • More than 10 -fold](https://reader035.vdocument.in/reader035/viewer/2022081615/5fe53cf908a39c50075cb536/html5/thumbnails/23.jpg)
For more information, contact CDC1-800-CDC-INFO (232-4636)TTY: 1-888-232-6348 www.cdc.gov
The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.